The Cooper Companies, Inc. $COO Shares Purchased by Alecta Tjanstepension Omsesidigt

Alecta Tjanstepension Omsesidigt increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 15.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 1,563,000 shares of the medical device company’s stock after acquiring an additional 213,500 shares during the period. Alecta Tjanstepension Omsesidigt owned approximately 0.80% of Cooper Companies worth $107,112,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Bell Investment Advisors Inc increased its position in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies in the 2nd quarter valued at about $36,000. MUFG Securities EMEA plc acquired a new position in Cooper Companies in the second quarter valued at about $42,000. IFP Advisors Inc boosted its stake in Cooper Companies by 2,647.8% during the third quarter. IFP Advisors Inc now owns 632 shares of the medical device company’s stock worth $43,000 after buying an additional 609 shares during the period. Finally, Quent Capital LLC purchased a new position in Cooper Companies during the third quarter worth about $44,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $71.17 on Thursday. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $89.83. The firm has a market cap of $13.89 billion, a PE ratio of 35.23, a price-to-earnings-growth ratio of 1.86 and a beta of 1.02. The company’s 50 day moving average is $80.49 and its two-hundred day moving average is $76.01.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the firm posted $0.92 earnings per share. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Activity at Cooper Companies

In other news, Director Cynthia L. Lucchese bought 1,784 shares of the business’s stock in a transaction that occurred on Monday, December 22nd. The shares were purchased at an average cost of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the purchase, the director owned 9,445 shares of the company’s stock, valued at approximately $793,946.70. This represents a 23.29% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.08% of the company’s stock.

Analysts Set New Price Targets

COO has been the topic of a number of research analyst reports. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Mizuho set a $100.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. William Blair raised Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Finally, Stifel Nicolaus set a $95.00 price target on Cooper Companies and gave the stock a “buy” rating in a research note on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.